These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 24731547

  • 1. Factors associated with medication adherence and persistence of treatment for hypertension in a Medicaid population.
    Baggarly SA, Kemp RJ, Wang X, Magoun AD.
    Res Social Adm Pharm; 2014; 10(6):e99-e112. PubMed ID: 24731547
    [Abstract] [Full Text] [Related]

  • 2. Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients.
    Schulz M, Krueger K, Schuessel K, Friedland K, Laufs U, Mueller WE, Ude M.
    Int J Cardiol; 2016 Oct 01; 220():668-76. PubMed ID: 27393848
    [Abstract] [Full Text] [Related]

  • 3. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
    Patel BV, Remigio-Baker RA, Thiebaud P, Preblick R, Plauschinat C.
    BMC Fam Pract; 2008 Nov 06; 9():61. PubMed ID: 18990240
    [Abstract] [Full Text] [Related]

  • 4. Persistence with Antihypertensive Medications in Uncomplicated Treatment-Naïve Patients: Effects of Initial Therapeutic Classes.
    Ah YM, Lee JY, Choi YJ, Kim B, Choi KH, Kong J, Oh JM, Shin WG, Lee HY.
    J Korean Med Sci; 2015 Dec 06; 30(12):1800-6. PubMed ID: 26713055
    [Abstract] [Full Text] [Related]

  • 5. Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy.
    Dickson M, Plauschinat CA.
    Am J Cardiovasc Drugs; 2008 Dec 06; 8(1):45-50. PubMed ID: 18303937
    [Abstract] [Full Text] [Related]

  • 6. Antihypertensive drug prescribing and persistence among new elderly users: implications for persistence improvement interventions.
    Tu K, Anderson LN, Butt DA, Quan H, Hemmelgarn BR, Campbell NR, McAlister FA, Hypertension Outcome and Surveillance Team.
    Can J Cardiol; 2014 Jun 06; 30(6):647-52. PubMed ID: 24882536
    [Abstract] [Full Text] [Related]

  • 7. Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia.
    Gadzhanova S, Roughead EE, Bartlett LE.
    Eur J Clin Pharmacol; 2016 Jun 06; 72(6):765-71. PubMed ID: 26961086
    [Abstract] [Full Text] [Related]

  • 8. Persistence with antihypertensives in uncomplicated treatment-naïve very elderly patients: a nationwide population-based study.
    Choi KH, Yu YM, Ah YM, Chang MJ, Lee JY.
    BMC Cardiovasc Disord; 2017 Aug 24; 17(1):232. PubMed ID: 28836946
    [Abstract] [Full Text] [Related]

  • 9. Hypertension medication use and adherence among adults with developmental disability.
    Vacek JL, Hunt SL, Shireman T.
    Disabil Health J; 2013 Oct 24; 6(4):297-302. PubMed ID: 24060252
    [Abstract] [Full Text] [Related]

  • 10. Persistence to antihypertensive drug classes: A cohort study using the Swedish Primary Care Cardiovascular Database (SPCCD).
    Qvarnström M, Kahan T, Kieler H, Brandt L, Hasselström J, Boström KB, Manhem K, Hjerpe P, Wettermark B.
    Medicine (Baltimore); 2016 Oct 24; 95(40):e4908. PubMed ID: 27749548
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antihypertensive medication adherence in the Department of Veterans Affairs.
    Siegel D, Lopez J, Meier J.
    Am J Med; 2007 Jan 24; 120(1):26-32. PubMed ID: 17208076
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in ontario.
    Friedman O, McAlister FA, Yun L, Campbell NR, Tu K, Canadian Hypertension Education Program Outcomes Research Taskforce.
    Am J Med; 2010 Feb 24; 123(2):173-81. PubMed ID: 20103027
    [Abstract] [Full Text] [Related]

  • 15. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations.
    Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F.
    J Manag Care Pharm; 2006 Apr 24; 12(3):239-45. PubMed ID: 16623608
    [Abstract] [Full Text] [Related]

  • 16. Persistence with treatment in newly treated middle-aged patients with essential hypertension.
    Perreault S, Lamarre D, Blais L, Dragomir A, Berbiche D, Lalonde L, Laurier C, St-Maurice F, Collin J.
    Ann Pharmacother; 2005 Sep 24; 39(9):1401-8. PubMed ID: 16076920
    [Abstract] [Full Text] [Related]

  • 17. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
    Adeyemi AO, Rascati KL, Lawson KA, Strassels SA.
    Clin Ther; 2012 Mar 24; 34(3):712-9. PubMed ID: 22381712
    [Abstract] [Full Text] [Related]

  • 18. Antihypertensive persistence and drug class.
    Marentette MA, Gerth WC, Billings DK, Zarnke KB.
    Can J Cardiol; 2002 Jun 24; 18(6):649-56. PubMed ID: 12107422
    [Abstract] [Full Text] [Related]

  • 19. [Persistence in drug therapy of hypertension among different treatment groups and comparison between fixed-dose combinations of ara II + calcium channel blockers vs ace inhibitors + calcium channel blockers].
    Waisman GD, Garfi LG, Izbizky GH, Tortella JJ.
    Rev Fac Cien Med Univ Nac Cordoba; 2012 Jun 24; 69(4):202-12. PubMed ID: 23751787
    [Abstract] [Full Text] [Related]

  • 20. Adherence to Oral Medications for Hypertension and Diabetes in Veterans with Comorbid Airflow Limitation.
    Melzer AC, Uman J, Au DH.
    Ann Am Thorac Soc; 2015 Jun 24; 12(6):831-7. PubMed ID: 25849224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.